PureTech News

Sign up for
email alerts

To receive news as it is released, please sign up.

Press releases
Press Releases - 2023-02-01
PureTech to Present at the SVB Securities Global Biopharma Conference
Press Releases - 2023-01-06
PureTech Founded Entity Akili Announces Pivotal Trial of EndeavorRx® in Adolescents with ADHD Shows Robust Improvements in Attention and Broader Clinical Outcomes
Press Releases - 2022-12-22
Wholly Owned Pipeline
PureTech Provides End of Year Report on Key Progress
Press Releases - 2022-12-19
Wholly Owned Pipeline
Wholly Owned Pipeline - LYT-300
PureTech's LYT-300 (Oral Allopregnanolone) Demonstrates Oral Bioavailability, Tolerability and GABAA Receptor Target Engagement in Healthy Volunteers
Press Releases - 2022-12-13
PureTech to Present at 41st Annual J.P. Morgan Healthcare Conference
Press Releases - 2022-12-12
Wholly Owned Pipeline
Wholly Owned Pipeline - LYT-200
PureTech Presents Data for LYT-200 Targeting Galectin-9 in Preclinical Leukemia Cancer Models at the 64th American Society of Hematology (ASH) Annual Meeting
Press Releases - 2022-12-09
PureTech Founded Entity Sonde Health Raises $19.25 Million Series B for Voice-Based Health Monitoring
Press Releases - 2022-12-07
PureTech Founded Entity Vor Bio Announces First AML Patient Successfully Transplanted with its Investigational Trem-cel (VOR33) and Tolerated Mylotarg™
Press Releases - 2022-11-30
Wholly Owned Pipeline
Wholly Owned Pipeline - LYT-310
PureTech Announces New Therapeutic Candidate, LYT-310, an Oral Form of Cannabidiol (CBD) Leveraging PureTech's Glyph™ Platform
Press Releases - 2022-11-17
PureTech to Present at Two Upcoming Investor Conferences
Displaying 1 - 10 of 329